Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide G pseudogene 12 (SNRPGP12) is a human pseudogene that shares sequence similarity to the functional gene encoding small nuclear ribonucleoprotein polypeptide G, a component of the spliceosomal machinery. However, SNRPGP12 itself is not protein-coding, and there is no evidence it is transcribed or plays a regulatory function. Like other pseudogenes, it is classified as a non-coding genomic locus, typically considered to lack biological activity, except in cases where pseudogenes function as regulatory RNAs by competing for microRNA binding — a function only demonstrated for a few well-studied cases. SNRPGP12 is not considered a receptor, enzyme, transporter, or established disease gene. In summary: SNRPGP12 is a pseudogene, not a protein-coding gene or therapeutic target. It is not considered a receptor or drug target, and has no recognized biological or disease role, documented function, or clinical relevance at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide G pseudogene 12 (SNRPGP12).